Viewing StudyNCT00290407



Ignite Creation Date: 2024-05-05 @ 4:40 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00290407
Status: TERMINATED
Last Update Posted: 2018-05-04
First Post: 2006-02-09

Brief Title: Rituximab Plus Beta-Glucan in Chronic Lymphocytic LeukemiaCLLSmall Lymphocytic Lymphoma SLL
Sponsor: University of Louisville
Organization: University of Louisville

Organization Data

Organization: University of Louisville
Class: OTHER
Study ID: 00806
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: University of Louisville
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
James Graham Brown Cancer Center OTHER